Different spectrum of vascular complications after angio-seal deployment or manual compression

Journal of Invasive Cardiology

Volumn 24, Issue 3, 2012, Pages 90-96

  Lupi, Alessandro ^a   Rognoni, Andrea ^a   Secco, Gioel Gabrio ^b   Lazzero, Maurizio ^a   Plebani, Laura ^a   Cossa, Giuseppe ^c   Reale, Danilo ^c   Nardi, Federico ^d   Sansa, Mara ^a   Bongo, Angelo S ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c SANT'ANDREA HOSPITAL   (Italy)

^d Castelli Hospital   (Italy)

Author keywords

cardiac catheterization; groin hematoma; vascular closure device; vascular complications

Indexed keywords

ADULT; AGED; ANGIO SEAL; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPRESSION THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FALSE ANEURYSM; FEMALE; HEMATOMA; HOSPITAL DISCHARGE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; THROMBOSIS;

AGED; ANEURYSM, FALSE; FEMALE; FEMORAL ARTERY; GROIN; HEART CATHETERIZATION; HEMATOMA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PRESSURE; PREVALENCE; PROSPECTIVE STUDIES; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84858417673     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Michalis LK, Rees MR, Patsouras D, et al. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angio-Seal, VasoSeal and Duett). Cardiovasc Intervent Radiol. 2002;25(5):423-429. (Pubitemid 36919613)
2. Kapadia SR, Raymond R, Knopf W, et al. The 6 Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol. 2001;87(6):789-791. (Pubitemid 32209102)
3. Eggebrecht H, Haude M, von Birgelen C, et al. Early clinical experience with the 6 French Angio-Seal device: immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures. Catheter Cardiovasc Interv. 2001;53(4):437-442. (Pubitemid 32729237)
4. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40(1):78-83. (Pubitemid 34701380)
5. Kim HY, Choo SW, Roh HG, et al. Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab, or thrombolytics during percutaneous endovascular procedures. Korean J Radiol. 2006;7(1):35-40. (Pubitemid 43389064)
6. Cura FA, Kapadia SR, L'Allier PL, et al. Safety of femoral closure devices after percutaneous coronary interventions in the era of glyco-protein IIb/IIIa platelet blockade. Am J Cardiol. 2000;86(7):780-782.
7. Chevalier B, Lancelin B, Koning R, et al; HEMOSTASE trial investigators. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv. 2003;58(3):285-291. (Pubitemid 36259212)
8. Van Den Broek T, Liqui Lung P F, Suttorp MJ, Eefting FD, Schipper ME, Vink A. Vascular occlusion as a late complication of the An-gio-Seal closure device. A review of literature. Minerva Cardioangiol. 2007;55(6):815-819. (Pubitemid 351169842)
9. Mehta SK, Frutkin AD. Correspondence to article: closure of the femoral artery after cardiac catheterization-a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv. 2008;72(4):586.
10. Patel MR, Jneid H, Derdeyn C P, et al. Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation. 2010;122(18):1882-1893.
11. Marso S P, Amin A P, House JA, et al. National Cardiovascular Data Registry. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156-2164.
12. Dauerman HL, Rao SV, Resnic FS, Applegate RJ. Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol. 2011;58(1):1-10.
13. Amin FR, Yousufuddin M, Stables R, et al. Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the Angio-Seal device vs the Femostop device. Int J Cardiol. 2000;76(2-3):235-240.
14. Dangas G, Mehran R, Kokolis S, et al. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38(3):638-641. (Pubitemid 32835728)
15. Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291(3):350-357. (Pubitemid 38101608)
16. Martin JL, Pratsos A, Magargee E, et al. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv. 2008;71(1):1-5. (Pubitemid 351158339)
17. Veasey RA, Large JK, Silberbauer J, et al. A randomised controlled trial comparing StarClose and Angio-Seal vascular closure devices in a district general hospital-the SCOAST study. Int J Clin Pract. 2008;62(6):912-918. (Pubitemid 351691496)
18. Deuling JH, Vermeulen R P, Anthonio RA, et al. Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression. Catheter Cardiovasc Interv. 2008;71(4):518-523. (Pubitemid 351498096)
19. Rastan A, Sixt S, Schwarzwälder U, et al. VIPER-2: a prospective, randomized single-center comparison of 2 different closure devices with a hemostatic wound dressing for closure of femoral artery access sites. J Endovasc Ther. 2008;15(1):83-90. (Pubitemid 351252236)
20. Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44(6):1200-1209. (Pubitemid 39208874)
21. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol. 2004;16(5):243-246. (Pubitemid 38637895)
22. Bangalore S, Arora N, Resnic FS. Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circ Cardio-vasc Interv. 2009;2(6):549-556.
23. Park Y, Roh HG, Choo SW, et al. Prospective comparison of collagen plug (Angio-Seal) and suture-mediated (the Closer S) closure devices at femoral access sites. Korean J Radiol. 2005;6(4):248-255. (Pubitemid 43128011)
24. Abando A, Hood D, Weaver F, Katz S. The use of the Angio-Seal device for femoral artery closure. J Vasc Surg. 2004;40(2):287-290. (Pubitemid 39055891)
25. Upponi SS, Ganeshan AG, Warakaulle DR, et al. Angio-Seal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures-a randomized controlled trial. Eur J Radiol. 2007;61(2):332-334. (Pubitemid 46096683)
26. Hermanides RS, Ottervanger J P, Dambrink JH, et al. Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison. J Invasive Cardiol. 2010;22(12):562-566.
27. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: The Twenty-Sixth Annual SAS Users Group International Conference. Cary, NC: SAS Institute, 2004;214-226.
28. Black PE. Greedy algorithm. In: Black PE, ed. Dictionary of Algorithms and Data Structures online. Gaithersburg, MD: US National Institute of Standards and Technology; February 2, 2005. http://www. itl.nist.gov/div897/sqg/dads/ HTML/greedyalgo.html.
29. Lupi A, Lazzero M, Plebani L, Sansa M, Bongo AS. Safety and efficacy of the new Angio-Seal Evolution closure device: a single-center experience. J Invasive Cardiol. 2011;23(4):150-155.
30. Behan MW, Large JK, Patel NR, Lloyd GW, Sulke AN. A randomised controlled trial comparing the routine use of an Angio-Seal STS device strategy with conventional femoral haemostasis methods in a district general hospital. Int J Clin Pract. 2007;61(3):367-372.
31. Assali AR, Sdringola S, Moustapha A, et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv. 2003;58(1):1-5. (Pubitemid 36055291)
32. Resnic FS, Arora N, Matheny M, Reynolds MR. A cost-minimization analysis of the Angio-Seal vascular closure device following percutaneous coronary intervention. Am J Cardiol. 2007;99(6):766-770. (Pubitemid 46365595)
33. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 Pt 2):757-763. (Pubitemid 27446562)